Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Epidermolysis Bullosa - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Epidermolysis Bullosa (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Epidermolysis Bullosa and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
154 pages
Hepatitis A - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hepatitis A (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis A and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
33 pages
Narcolepsy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Narcolepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Narcolepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
86 pages
Acne Vulgaris - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Acne Vulgaris (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Acne Vulgaris and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
224 pages
Allergic Rhinitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
164 pages
Angina (Angina Pectoris) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
78 pages
Atherosclerosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Atherosclerosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Atherosclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
245 pages
Bone Metastasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bone Metastasis (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Bone Metastasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
127 pages
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2020
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Chronic Kidney Disease (Chronic Renal Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
276 pages
Endometriosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Endometriosis (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
148 pages
Essential Thrombocythemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Essential Thrombocythemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Essential Thrombocythemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
115 pages
Fallopian Tube Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Fallopian Tube Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Fallopian Tube Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
1496 pages
Head And Neck Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... . The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development ...
April 2020
2943 pages
Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Idiopathic Pulmonary Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Idiopathic Pulmonary Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
503 pages
Kidney Fibrosis - Pipeline Review, H1 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Kidney Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
174 pages
Measles - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Measles (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Measles and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
43 pages
Osteoarthritis Pain - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Osteoarthritis Pain - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Osteoarthritis Pain (Central Nervous System), complete with analysis by stage of development ...
April 2020
245 pages
Osteoporosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
353 pages
Parkinson's Disease - Pipeline Review, H1 2020
US$ 2,500.00
... . The Parkinson's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
1201 pages
Peanut Allergy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Peanut Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Peanut Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
158 pages
Premature Ejaculation - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Premature Ejaculation (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Ejaculation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
41 pages
Rotavirus Infections - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rotavirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rotavirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
55 pages
Stroke - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
716 pages
Asthma - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
758 pages
Overactive Bladder - Pipeline Review, H1 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Overactive Bladder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
127 pages
Ulcerative Colitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ulcerative Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Ulcerative Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
671 pages
Allergic Conjunctivitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Allergic Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Allergic Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
97 pages
Bronchiectasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bronchiectasis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchiectasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
90 pages
Eosinophilic Esophagitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Eosinophilic Esophagitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Eosinophilic Esophagitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
131 pages
Klebsiella pneumoniae Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Klebsiella pneumoniae Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Klebsiella pneumoniae Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
128 pages
Polycystic Kidney Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Polycystic Kidney Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Kidney Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
127 pages
Rosacea - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rosacea (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Rosacea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
90 pages
Yellow Fever - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Yellow Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Yellow Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
57 pages
Cystic Fibrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
502 pages
Sickle Cell Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Sickle Cell Disease (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
271 pages
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chagas Disease (American Trypanosomiasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chagas Disease (American Trypanosomiasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
92 pages
Post Menopausal Osteoporosis - Pipeline Review, H1 2020
US$ 2,000.00
... . The Post Menopausal Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Post Menopausal Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
129 pages
Rabies - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rabies (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rabies and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
96 pages
Optic Neuritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Optic Neuritis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Optic Neuritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
48 pages
Oropharyngeal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Oropharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
550 pages
Vitiligo - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Vitiligo (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Vitiligo and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
144 pages
Acinetobacter Infections - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Acinetobacter Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Acinetobacter Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
192 pages
Cataract - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cataract (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Cataract and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
40 pages
Gastric Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Gastric Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2020
2197 pages
Haemophilus influenzae Type B Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Haemophilus influenzae Type B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Haemophilus influenzae Type B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
69 pages
Inclusion Body Myositis (IBM) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Inclusion Body Myositis (IBM) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
70 pages
Low Back Pain - Pipeline Review, H1 2020
US$ 2,000.00
... . The Low Back Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development ...
April 2020
130 pages
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2020
403 pages